References
- Franz T.J., Tojo K., Shah K.R., Kydonieus A. Transdermal delivery. Treatise on Controlled Drug Delivery, A. Kydonieus. Marcel Dekker, Inc., New York 1992; 341–421
- Baker R.W., Heller J. Material selection for transdermal delivery systems. Transdermal Drug Delivery, J. Hadgraft, R.H. Guy. Marcel Dekker, Inc., New York 1989; 293–311
- Keshery P.R., Huang Y.C., Chien Y.W. Mechanism of transdermal controlled nitroglycerin administration (III) control of skin permeation rate and optimization. Drug Dev. Ind. Pharm. 1985; 11: 1213–1253
- Ho H., Chien Y.W. Kinetic evaluation of transdermal nicotine delivery systems. Drug Dev. Ind. Pharm. 1993; 19(3)295–313
- Ghosh T.K., Habib M.J., Childs K., Alexander M. Transdermal delivery of metoprolol I: comparison between hairless mouse and human cadaver skin and effect of n-decylmethyl sulfoxide. Int. J. Pharm. 1992; 88: 391–396
- Ghosh T.K., Chiao C.S., Gokhale R.D. In vitro release and permeation of levobunolol from various transdermal formulations. Int. J. Pharm. 1992; 82: 39–45
- Roy S.D., Gutierrez M., Flynn G.L., Cleary G.W. Controlled transdermal delivery of fentanyl: characterization of pressure-sensitive adhesives for matrix patch design. J. Pharm. Sci. 1995; 85(5)491–495
- Jenkins A.W. Developing the fematrix transdermal patch. Pharm. J. 1995; 255: 179–181
- Pfister W.R., Woodard J.T., Grigoras S. Development of drug-compatible adhesives for transdermal drug delivery devices. Pharm. Tech. 1992; 1: 42–83
- Ghosh T.K., Adir J., Xiang S., Onyilofur S. Transdermal delivery of metoprolol II: in vitro skin permeation and bioavailability in hairless rats. J. Pharm. Sci. 1995; 84(2)158–160
- Yamaguchi Y., Sugibayashi K., Takeda T., Seki T., Morinoto Y. Release of clonidine hydrochloride from pressure-sensitive adhesive matrices prepared by emulsion type acrylate polymer. Chem. Pharm. Bull. 1995; 43(10)1807–1809
- Lewis D., Paulo M., Faustino E., Farinha A. In vitro comparative studies of transdermal nicotine delivery systems. Int. J. Pharm. 1997; 148: 177–189
- Guy R.H., Hadgraft J. Rate control in transdermal drug delivery?. Int. J. Pharm 1992; 82: R1–R6
- USP 24, NF 19: The United States Pharmacopeia The National FormularyNicotine transdermal systemThe United States Pharmacopeia Convention, Inc.11791181 1999
- Baker R.W., Kochinke C., Huang C. Novel Transdermal Nicotine Patch. US Patent 4,839,174, June 13, 1989
- Kydonieus A.F. Transdermal delivery from solid multilayered polymeric reservoir systems. Transdermal Delivery of Drugs, A.F. Kydonieus, B. Berner. CRC Press, Inc., Boca Raton 1987; Vol. 1: 148–149
- Bonny J.D., Leuenberger H. Matrix type controlled release systems: II percolation effects in non-swellable matrices. Pharm. Acta. Helv. 1993; 68: 25–33
- El-Arini S.K., Leuenberger H. Modeling of drug release from polymer matrices: effect of drug loading. Int. J. Pharm. 1995; 121: 141–148
- Caraballo I., Melgoza L.M., Alvarez-Fuentes J., Soriano M.C., Rabasco A.M. Design of controlled release inert matrixes of naltrexone hydrochloride based on percolation concepts. Int. J. Pharm. 1999; 181: 23–30
- Rao P.R., Diwan P.V. Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev. Ind. Pharm. 1998; 24(4)327–336
- Ponjanyakul T., Prakongpan S., Priprem A. Permeation studies comparing cobra skin with human skin using nicotine transdermal patches. Drug Dev. Ind. Pharm. 2000; 26(6)635–642
- Hadgraft J., Wolff H.M. In vitro/in vivo correlation in transdermal drug delivery. Dermal Absorption and Toxicity Assess-ment, M.S. Roberts, K.A. Walters. Marcel Dekker, Inc., New York 1998; 269–279
- Gupta S.K., Benowitz N.L., Jacob P., Rolf C.N., Gorsline J. Bioavailability and absorption kinetics of nicotine following application of a transdermal system. Br. J. Clin. Pharmacol. 1993; 36: 221–227